Our president, Donald Trump , tells us that “what we are doing is big,” so there might be economic consequences to come that we don’t like. But he can’t change the plan, whatever the heck the plan is. Our Treasury secretary, Scott Bessent, comes on CNBC and tells us that …
The Magnificent Seven companies reporting in the week ahead could unlock the next leg of the rally, as investors bet that earnings growth fueled by artificial intelligence could power a market some worry has gone to excess. The Federal Reserve will also hold its January meeting, with key inflation data …
A box of Ozempic and contents sit on a table in Dudley, North Tyneside, Britain, October 31, 2023. George Frey | Reuters The Biden administration on Friday unveiled the next 15 prescription drugs that will be subject to price negotiations between manufacturers and Medicare, kicking off the second phase of …
Trends may be shifting in favor of biotech stocks in 2025 after several years of poor performance, but it would still be wise to place your bets carefully on some of the most innovative names. “We’re still optimistic on the outlook for biotech,” said Stacey Sears, senior vice president and …
The U.S. presidential election beckons and even though nearly 75 million people have already voted, according to NBC News , nothing seems to have leaked out. You would figure the hedge fund algorithms would have picked up something by now, but I haven’t seen any confirmed bets made either way. …
Activists protest the price of prescription drug costs in front of the U.S. Department of Health and Human Services building in Washington, D.C., on Oct. 6, 2022. Anna Moneymaker | Getty Images The Biden administration on Thursday released prices for the first 10 prescription drugs that were subject to landmark …
This year’s presidential election is already sending health-care stocks on a wild ride. Historically, shifts in political control have created “increased volatility” across the health care sector, sending investors “to look for areas of safety,” Raymond James analyst Chris Meekins said in a July 7 note. “This election is likely …
While debate rages on about when the Federal Reserve might start cutting interest rates, biotech industry analysts are making the case that the argument for stocks in the sector is growing. The central bank has held rates steady since last July as it patiently waits for more signs that inflation …
Here are Thursday’s biggest calls on Wall Street: Wells Fargo reiterates Bank of America as overweight Wells Fargo raised its price target on Bank of America to $44 per share from $40. “We nudge 1Q24 EPS higher owing to better than previously est. capital mkts, partially offset by est. FDIC …
